Rock Springs Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $49.1M | Sell |
|
|||||
|
2023
Q3 | $49.3M | Buy |
|
|||||
|
2023
Q2 | $40.5M | Buy |
|
|||||
|
2023
Q1 | $39.6M | Buy |
|
|||||
|
2022
Q4 | $36.5M | Sell |
|
|||||
|
2022
Q3 | $60.5M | Buy |
|
|||||
|
2022
Q2 | $56.7M | Buy |
|
|||||
|
2022
Q1 | $46M | Buy |
|
|||||
|
2021
Q4 | $60.2M | Buy |
|
|||||
|
2021
Q3 | $62.5M | Buy |
|
|||||
|
2021
Q2 | $51.5M | Sell |
|
|||||
|
2021
Q1 | $55.4M | Sell |
|
|||||
|
2020
Q4 | $82M | Buy |
|
|||||
|
2020
Q3 | $57.9M | Hold |
|
|||||
|
2020
Q2 | $39.8M | Buy |
|
|||||
|
2020
Q1 | $26.3M | Buy |
|
|||||
|
2019
Q4 | $38.7M | Buy |
|
|||||
|
2019
Q3 | $20.1M | Buy |
|
|||||
|
2019
Q2 | $20.9M | Buy |
|
|||||
|
2019
Q1 | $13.2M | Buy |
|
|||||
|
2018
Q4 | $6.36M | Sell |
|
|||||
|
2018
Q3 | $11.3M | Hold |
|
|||||
|
2018
Q2 | $11.8M | Buy |
|
|||||
|
2018
Q1 | $5.8M | Buy |
|
|||||
|
2017
Q4 | $3.29M | Buy |
|